Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.

G. Tocci, L. Antonelli, E. Boumis, M. Colaiacomo, P. Guarascio, C. Struglia, G. Tossini, G. Visco

Research output: Contribution to journalArticlepeer-review

Abstract

A pilot study is described, in which 25 chronic CDH patients were treated with 3 MU recombinant alpha-interferon per week for 4 months. Improvement was transient and no long-term effects were noted. Side effects were well tolerated and reversible so that longer treatment and higher dosages should be possible.

Original languageEnglish
Pages (from-to)306-307
Number of pages2
JournalArchives of virology. Supplementum
Volume4
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Immunology and Microbiology(all)

Fingerprint Dive into the research topics of 'Long-term effects of recombinant leukocyte alpha interferon in the treatment of chronic delta hepatitis.'. Together they form a unique fingerprint.

Cite this